)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Abpro Holdings
Abpro Holdings (ABP) investor relations material
Abpro Holdings Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary14 Aug, 2026
Executive summary
Focused on next-generation antibody therapeutics in immuno-oncology, ophthalmology, and infectious disease, with lead candidates ABP-102 and ABP-201 in early-stage development.
Securities delisted from Nasdaq in February 2026, now trading on OTC Pink Limited Market, impacting liquidity and capital-raising ability.
Significant cost reductions implemented, including R&D personnel furloughs and terminations in late 2025.
Financial highlights
No revenue generated for the three or six months ended June 30, 2026 or 2025.
Net loss for Q2 2026 was $0.9M, a 68% improvement from $3.0M in Q2 2025; six-month net loss was $2.0M, a 71% improvement from $6.9M in 2025.
Operating expenses for Q2 2026 were $1.2M, down 48% year-over-year; six-month operating expenses were $2.1M, down 60%.
Cash as of June 30, 2026 was $4.2M.
Outlook and guidance
Management concluded there is substantial doubt about the ability to continue as a going concern within one year due to insufficient cash to cover liabilities.
Plans to seek additional funding through equity, debt, collaborations, and grants; may need to further reduce operations if funding is not secured.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Abpro Holdings
- Net loss improved to $1.0M, but delisting and legal risks threaten liquidity and operations.ABP
Q1 2026 - Net loss narrowed to $2.9M in 2025, but liquidity and going concern risks remain acute.ABPQ4 2025
- Vote seeks to extend the business combination deadline, with redemption rights preserved.ABPProxy Filing
- Preclinical biotech with major funding needs registers large share and warrant resale, faces high dilution risk.ABPRegistration Filing
- Preclinical biotech with urgent capital needs registers up to 20.7M shares for resale under $50M SEPA.ABPRegistration Filing
- Shareholders will vote on extending the business combination deadline or face company liquidation.ABPProxy Filing
- Key votes include director re-election, auditor ratification, and a 1-for-10 reverse stock split.ABPProxy Filing
- Biotech registers major share resale and warrant exercise, faces funding and clinical risks.ABPRegistration Filing
- Biotech seeks $50M equity via SEPA amid going concern, dilution, and Nasdaq risks.ABPRegistration Filing
Next Abpro Holdings earnings date
Q3 202620 Nov, 2026
Abpro Holdings
Next Abpro Holdings earnings date
Q3 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)